跳至主要内容
临床试验/NCT02060734
NCT02060734撤回4 期

Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated disorder-a Randomized Controlled Trial

Hamilton Health Sciences Corporation4 个研究点 分布在 1 个国家开始时间: 2015年10月最近更新:
适应症

试验速览

阶段
4 期
状态
撤回
试验地点
4
主要终点
pain

研究概览

简要总结

To determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury.

详细描述

This is a double-blind, randomized controlled trial to determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury. Outcomes include pain, objective assessment, self-report function recovery, impact on work performance and globe perceived effects which will be assessed 5 minutes, 2 and 6 weeks following injection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • fulfill the Grade II Quebec Task Force classification of WAD,
  • with identifiable myofascial trigger points ( which occur with or without a taut band),
  • reproduction of recognizable pain with sustained pressure ( up to 10 seconds) on trigger points
  • aged 18 to 70
  • a good understanding of informed consent and willing to attend this trial.

排除标准

  • have serious injury such as fracture and internal bleeding
  • suspicion of upper cervical instability or neurological deficits
  • clinical evidence of radiculopathy
  • a history of active cancer, central nerve disorder, blood clotting disorders, needle phobia
  • anticoagulant medication user
  • previous experience with any type of needling for myofascial pain

结局指标

主要结局

pain

时间窗: 2 weeks following injection

10 cm Visual Analog Scale

次要结局

  • work performance(Immediately, 2 and 6 weeks after injection)
  • pain(6 weeks following injection)
  • globe perceived effects(Immediately, 2 and 6 weeks after injection)
  • cervical range of motion(Immediately, 2 and 6 weeks after injection)
  • self-report neck disability(Immediately, 2 and 6 weeks after injection)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maggie Qiyun Shi

Graduate student, Western University

Hamilton Health Sciences Corporation

研究点 (4)

Loading locations...

相似试验